miRNAs at the C. elegans neuromuscular junction: potential SMA modifiers
miRNAs at the C. elegans neuromuscular junction: potential SMA modifiers
批准号:
9043746
负责人:
Patrick OHern
金额:
$3.77万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-04-01 至 2016-12-31
关键词:
3&apos Untranslated RegionsAffectAldicarbAmericanAnimal ModelAnimalsBehavioral GeneticsBindingBiogenesisBioinformaticsBiological AssayBoxingCaenorhabditis elegansComplexDNA Sequence AlterationDataDefectDiseaseFluorescenceGemin3GeneticGenetic EpistasisHealthHela CellsKnowledgeLeadLinkMEL GeneMessenger RNAMethodsMicroRNAsModelingMotor NeuronsMusMutationNerve DegenerationNeurodegenerative DisordersNeuromuscular JunctionNeuronsOrthologous GenePathway interactionsPlayProteinsPublic HealthPumpRNARNA HelicaseRNA InterferenceRegulationReporterRoleSMN protein (spinal muscular atrophy)SMN1 geneSignal TransductionSpinal Muscular AtrophySynapsesSynaptic TransmissionTestingTissuesUnited StatesUntranslated RNAWorkbasecholinergicdesigndisease-causing mutationinfant deathknock-downloss of functionmotor neuron degenerationmouse modelmutantmutation carriernervous system disorderneuron lossoverexpressionprotein expressionresearch studyscreeningsynaptic functiontool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Spinal Muscular Atrophy (SMA) is a neurological disorder characterized by loss of lower motor neurons. This degeneration is caused by genetic mutations that lead to decreased levels of Survival of Motor Neuron (SMN) protein. It is currently unknown how SMN reduction results in neuronal death, however recent evidence suggests that miRNA disruption may play a role. miRNAs are small non-coding RNAs predicted to regulate protein expression of a vast number of mRNAs. The RNA helicase Gemin3 pulls down with both SMN and numerous miRNAs in cultured mouse motor neurons. I hypothesize that Gemin3-associated miRNAs are misregulated in smn-1 loss-of-function(lf) animals leading to NMJ defects. smn-1(ok355) animals are defective on aldicarb, have reduced pumping and altered levels of synaptic proteins, suggesting neuromuscular junction (NMJ) defects. My preliminary data shows that loss of the C. elegans Gemin3 ortholog, mel-46, results in similar NMJ defects. Using tissue-specific rescue analysis and genetic epistasis, I will show that mel-46 is downstream of smn-1 in a pathway influencing NMJ signaling. Additionally, I have identified C. elegans orthologs of Gemin3-associated miRNAs that are necessary for proper NMJ synaptic transmission similar to smn-1 and mel-46. I will compile lists of potential mRNA targets for these candidate miRNAs using online bioinformatics tools; assigning priority to conserved targets with known synaptic function. For each potential mRNA target, I will confirm miRNA regulation and investigate whether miRNA function is altered in smn-1 lf and mel-46 lf. Furthermore, I have designed experiments to show loss of miRNA function in smn-1 lf animals is caused by mel-46 reduction. Using motor neurons from a SMA mouse model, I will show that the relationship between SMN, Gemin3 and miRNA function is conserved across species. These experiments will advance our knowledge of how SMN protein contributes to essential neuronal functions and expand our understanding of how miRNA misregulation may contribute to neurodegeneration.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
miRNAs at the C. elegans neuromuscular junction: potential SMA modifiers
-
批准号:8908383
-
项目类别:
-
资助金额:$4.31万
-
财政年份:2015
-
负责人:Patrick OHern
-
依托单位:
海外基金